Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery
and development of novel therapeutic agents ranging from biologics to small molecules.
We aim to meet your research needs. Visit numerous concurrent sessions for informative presentations, lively dialogue, and meaningful connections with peers. Customize your experience further through focused short
courses, interactive discussions, and networking options that help you engage with experts and solutions providers.
Our 20th Annual event brings back popular topics like PROTACs and RNA plus new programming on
immunomodulation, antivirals, neurodegeneration targets, KRAS,